Post-mortem analysis of suicide victims shows ABCB1 haplotype 1236T-2677T-3435T as a candidate predisposing factor behind adverse drug reactions in females.

Author: HaukkaJari, PaloJukka U, RahikainenAnna-Liina, SajantilaAntti

Paper Details 
Original Abstract of the Article :
Genetic variation in efflux transporter, permeability glycoprotein (P-gp), has recently been associated with completed violent suicides and also violent suicide attempts. As depression is known to be a risk factor for suicide and many antidepressants are P-gp substrates, it has been speculated that ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1097/FPC.0000000000000328

データ提供:米国国立医学図書館(NLM)

ABCB1 Haplotype 1236T-2677T-3435T: A Hidden Oasis in the Desert of Suicide

Suicide, a tragic and complex phenomenon, often involves a combination of genetic, environmental, and psychological factors. This study delves into the potential role of genetic variation in the efflux transporter, permeability glycoprotein (P-gp), in completed suicides. Researchers analyzed post-mortem data from suicide victims, identifying a specific ABCB1 haplotype (1236T-2677T-3435T) that may be associated with increased susceptibility to adverse drug reactions in females. This research, like a hidden oasis in the vast desert of suicide, offers a glimpse into the intricate interplay between genetics and suicidal behavior, potentially providing valuable insights for understanding and preventing suicide.

A New Perspective on Suicide Risk

This study, my dear readers, provides a new perspective on suicide risk, highlighting the potential role of genetic variation in influencing susceptibility to adverse drug reactions. The discovery of a specific ABCB1 haplotype linked to suicide in females underscores the importance of considering individual genetic differences when prescribing medications, particularly those that are substrates of P-gp. This research offers a valuable tool for understanding the complex interplay between genetics, medications, and suicidal behavior, potentially paving the way for more personalized and effective interventions.

A Path Towards Safer Medication Use

This research sheds light on a path towards safer medication use, particularly for those at risk of suicide. By understanding the potential role of genetic variation in influencing drug response, clinicians can make more informed decisions regarding medication selection and dosage, minimizing the risk of adverse effects. This study serves as a reminder that the journey towards preventing suicide requires a multidisciplinary approach, involving careful consideration of genetic, environmental, and psychological factors.

Dr. Camel's Conclusion

This study, my dear readers, is a reminder that the desert of suicide is fraught with complexity. Researchers are diligently seeking to unravel its mysteries, and the discovery of a genetic link to adverse drug reactions offers a valuable step towards understanding and potentially preventing this tragic phenomenon.

Date :
  1. Date Completed 2019-01-23
  2. Date Revised 2019-01-23
Further Info :

Pubmed ID

29481489

DOI: Digital Object Identifier

10.1097/FPC.0000000000000328

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.